“Scientifically knowledgeable, dedicated and pleasurable to interact with are the descriptors that come to mind when thinking of Sanjoy. I have known him for almost 10 years and had the pleasure to mentor and direct him while at JDRF. Sanjoy is an exceptional drug development scientist who has gained extensive experience in all aspects of diabetes and related complications of this disease. He is a true advocate of the people dealing with diabetes and strives in his professional life to bring new ideas for assessment that can be tested. Sanjoy’s dedication and commitment to scientific advancements in diabetes is commendable. ”
Activity
-
I am thrilled to announce that Diamyd Medical has received positive feedback from the FDA regarding an Accelerated Approval pathway for our…
I am thrilled to announce that Diamyd Medical has received positive feedback from the FDA regarding an Accelerated Approval pathway for our…
Liked by Sanjoy Dutta
-
Breakthrough T1D pushing the frontiers on Automated Insulin Delivery for people with type 1 diabetes (T1D) and others requiring insulin. Please reach…
Breakthrough T1D pushing the frontiers on Automated Insulin Delivery for people with type 1 diabetes (T1D) and others requiring insulin. Please reach…
Shared by Sanjoy Dutta
-
Check out the new request for applications from Breakthrough T1D: Development Of Devices And Drugs For Fully Automated Insulin Delivery At…
Check out the new request for applications from Breakthrough T1D: Development Of Devices And Drugs For Fully Automated Insulin Delivery At…
Liked by Sanjoy Dutta
Experience & Education
Publications
-
It’s Time to Move from the A1c to Better Metrics for Diabetes Control
DIABETES TECHNOLOGY & THERAPEUTICS
Recommendations received
1 person has recommended Sanjoy
Join now to viewMore activity by Sanjoy
-
I am raising research dollars for type 1 diabetes (T1D) as part of the Breakthrough T1D OneWalk (new name of JDRF). Last year our team the Diabetes…
I am raising research dollars for type 1 diabetes (T1D) as part of the Breakthrough T1D OneWalk (new name of JDRF). Last year our team the Diabetes…
Liked by Sanjoy Dutta
-
🌟 Exciting News! 🌟 We're thrilled to announce that Diamyd Medical has received its second U.S. FDA Fast Track designation for Diamyd®…
🌟 Exciting News! 🌟 We're thrilled to announce that Diamyd Medical has received its second U.S. FDA Fast Track designation for Diamyd®…
Liked by Sanjoy Dutta
-
Breakthrough T1D Appoints Matthew Cohn as Chair of the Non-Profit’s Global Mission Board - https://lnkd.in/epW_NNJr Follow Citybiz on LinkedIn -…
Breakthrough T1D Appoints Matthew Cohn as Chair of the Non-Profit’s Global Mission Board - https://lnkd.in/epW_NNJr Follow Citybiz on LinkedIn -…
Liked by Sanjoy Dutta
-
Absolutely thrilled for JDRF UK to have won the 2024 Healthcare & Medical Research #CharityAwards for the development, research and NICE approval of…
Absolutely thrilled for JDRF UK to have won the 2024 Healthcare & Medical Research #CharityAwards for the development, research and NICE approval of…
Liked by Sanjoy Dutta
-
Our Chief Marketing Officer, Pam Morrisroe, sat down with Ad Age to discuss our new brand identity and how it reflects our bold vision for a world…
Our Chief Marketing Officer, Pam Morrisroe, sat down with Ad Age to discuss our new brand identity and how it reflects our bold vision for a world…
Liked by Sanjoy Dutta
-
We will add studies of the benefit on continous glucose monitoring as well as impact on retinopathy supported by @BreaktrhoughT1D / JDRF International
We will add studies of the benefit on continous glucose monitoring as well as impact on retinopathy supported by @BreaktrhoughT1D / JDRF International
Liked by Sanjoy Dutta
-
Sammen om et bedre liv med type 1-diabetes! Sådan er vores slogan for nyt studie som nu er i gang og skal teste multifaktoriel intervention til at…
Sammen om et bedre liv med type 1-diabetes! Sådan er vores slogan for nyt studie som nu er i gang og skal teste multifaktoriel intervention til at…
Liked by Sanjoy Dutta
-
I’m unable to be with my colleagues today, but so pleased that Breakthrough T1D rang the Nasdaq opening bell this morning. Thank you Sydney Yovic for…
I’m unable to be with my colleagues today, but so pleased that Breakthrough T1D rang the Nasdaq opening bell this morning. Thank you Sydney Yovic for…
Liked by Sanjoy Dutta
-
JDRF Canada is building a foundation for T1D screening in Canada (https://bit.ly/3VVu0As) to detect the autoimmune attack prior to the presence of…
JDRF Canada is building a foundation for T1D screening in Canada (https://bit.ly/3VVu0As) to detect the autoimmune attack prior to the presence of…
Liked by Sanjoy Dutta
-
#OnThisDay in 1903, Marie Skłodowska Curie defended her doctoral thesis on radioactive substances at Université de la Sorbonne in Paris – becoming…
#OnThisDay in 1903, Marie Skłodowska Curie defended her doctoral thesis on radioactive substances at Université de la Sorbonne in Paris – becoming…
Liked by Sanjoy Dutta
-
Coming out of #ADA2024, I am feeling incredibly energized by the progress that’s been made in our industry over this past year and am very proud of…
Coming out of #ADA2024, I am feeling incredibly energized by the progress that’s been made in our industry over this past year and am very proud of…
Liked by Sanjoy Dutta
-
It was an Amazing #ADA2024! This was my last year as a Sci Session Planning Committee Member. It was a pleasure working with a dynamic team Diana…
It was an Amazing #ADA2024! This was my last year as a Sci Session Planning Committee Member. It was a pleasure working with a dynamic team Diana…
Liked by Sanjoy Dutta
-
Looking forward to giving a summary this evening!
Looking forward to giving a summary this evening!
Liked by Sanjoy Dutta
Other similar profiles
-
Aaron Kowalski
Connect -
Esther Latres
VP, Research at BreakthroughT1D
Connect -
Joshua Vieth
Connect -
Jason Gaglia, MD, MMSc
Section Head Joslin Diabetes, Asst Professor Harvard Medical School
Connect -
Jonathan Rosen
Director, Research at JDRF International
Connect -
Anastasia Albanese-O'Neill
On the hunt for a cure for type 1 diabetes; dedicated to expanding access to diabetes education. Opinions my own.
Connect -
Sydney Yovic
Connect -
Ulf Hannelius
Connect -
Valdemar Grill
Professor emeritus i NTNU
Connect -
Thomas Danne
Chief Medical Officer International, Breakthrough T1D
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Sanjoy Dutta in United States
-
Sanjoy Dutta
Marketing Manager, Global Digital Billing, Payments, Claims
-
Sanjoy Dutta
Bariatric and Laparoscopic General Surgeon
-
Sanjoy Dutta
Pursuing MBA at Wake Forest University
-
Sanjoy Dutta
--
4 others named Sanjoy Dutta in United States are on LinkedIn
See others named Sanjoy Dutta